Advances in Molecular Imaging of Breast and Gynecologic Cancers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 2141
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast and gynecological cancers are among the most prevalent cancers to afflict women worldwide. An early diagnosis of the initial disease or recurrence and personalized treatment can significantly reduce physical morbidity and psychological distress in affected patients.
Molecular imaging (MI) allows functional and metabolic characterization of malignant lesions using advanced imaging acquisition techniques that detect targeted imaging agents with specific properties. MI provides insights into the biologic processes responsible for oncogenesis, assessing molecular and cellular pathways. Some of the current applications of MI in oncology are screening in high-risk populations, diagnosis of the early stage disease or recurrence, systemic staging, evaluation and optimization of neoadjuvant, and hormonal or molecular targeted therapy. MI modalities include PET and SPECT scans using different radiotracers, hybrid imaging such as PET/CT or SPECT/CT, functional MRI, optical imaging and targeted molecular ultrasound. Moreover, some breast-targeted techniques have been developed such as dedicated breast gamma imaging and breast-specific PET, the latter including positron emission mammography and dedicated breast PET.
This Special Issue aims to collect original research and review articles depicting new radiopharmaceuticals and their applications or potential nanotechnologies used in the management of breast or gynecological cancers.
Dr. Diana Gherman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- gynecological cancers
- molecular imaging
- functional imaging
- radiotracer
- advance nanotechnologies in oncological management
